glp 1 cause kidney issues Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 receptor agonists in patients

Tirzepatide takes it a step further by also targeting GIP receptors, offering a dual action that provides even greater metabolic benefits

Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG (2018) Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti--Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea

Frequently Asked Questions Can low protein make GLP-1 constipation worse

Injectable B12, which is often recommended in severe deficiency cases, may cause more adverse effects, including diarrhea, itching, skin rash, headache, dizziness, nausea, or vomiting

Glutathione helps the liver work better and detoxify